Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Core EBITDA Growth

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 17.6827.6932.55-13.1679.82

What is the latest Core EBITDA Growth ratio of MARKSANS PHARMA ?

The latest Core EBITDA Growth ratio of MARKSANS PHARMA is 17.68 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202517.68
Mar202427.69
Mar202332.55
Mar2022-13.16
Mar202179.82

How is Core EBITDA Growth of MARKSANS PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 17.68
-36.15
Mar2024 27.69
-14.93
Mar2023 32.55
Positive
Mar2022 -13.16
Negative
Mar2021 79.82 -

Other Financial Ratios of MARKSANS PHARMA


Compare Core EBITDA Growth ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹8,080.6 Cr -15.5% -31.7% -2.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-15.5%

-31.7%

-2.1%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses